Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases.
about
Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasisRole of Inflammation in Muscle Homeostasis and MyogenesisMechanisms of Muscle Denervation in Aging: Insights from a Mouse Model of Amyotrophic Lateral SclerosisOngoing controversies surrounding cardiac remodeling: is it black and white-or rather fifty shades of gray?The quasi-parallel lives of satellite cells and atrophying muscleThe TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and diseaseCellular and molecular mechanisms of muscle atrophyHDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegenerationPostnatal muscle modification by myogenic factors modulates neuropathology and survival in an ALS mouse modelp53 suppresses muscle differentiation at the myogenin step in response to genotoxic stressNoninvasive imaging of in vivo MuRF1 expression during muscle atrophyMyogenin regulates denervation-dependent muscle atrophy in mouse soleus muscleThe methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophyCirculating MiRNAs as biomarkers of gait speed responses to aerobic exercise training in obese older adultsExercise-induced skeletal muscle remodeling and metabolic adaptation: redox signaling and role of autophagy.Myogenin regulates exercise capacity and skeletal muscle metabolism in the adult mouse.Inhibition of Janus kinase signaling during controlled mechanical ventilation prevents ventilation-induced diaphragm dysfunctionMyogenin regulates exercise capacity but is dispensable for skeletal muscle regeneration in adult mdx mice.Transcriptional coregulators: fine-tuning metabolism.Use of mRNA expression signatures to discover small molecule inhibitors of skeletal muscle atrophy.HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling.DNA methyltransferase 3a and mitogen-activated protein kinase signaling regulate the expression of fibroblast growth factor-inducible 14 (Fn14) during denervation-induced skeletal muscle atrophy.A systems biology approach identifies molecular networks defining skeletal muscle abnormalities in chronic obstructive pulmonary diseaseHabitual exercise plus dietary supplementation with milk fat globule membrane improves muscle function deficits via neuromuscular development in senescence-accelerated miceSkeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1Forkhead box O1 and muscle RING finger 1 protein expression in atrophic and hypertrophic denervated mouse skeletal muscle.Glycolysis-dependent histone deacetylase 4 degradation regulates inflammatory cytokine production.Expression of androgen receptor target genes in skeletal muscle.Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease.SREBP-1 transcription factors regulate skeletal muscle cell size by controlling protein synthesis through myogenic regulatory factors.MST1, a key player, in enhancing fast skeletal muscle atrophy.HDAC4 promotes Pax7-dependent satellite cell activation and muscle regeneration.Spermine oxidase maintains basal skeletal muscle gene expression and fiber size and is strongly repressed by conditions that cause skeletal muscle atrophy.miR-206 represses hypertrophy of myogenic cells but not muscle fibers via inhibition of HDAC4Improved knee extensor strength with resistance training associates with muscle specific miRNAs in older adults.Histone deacetylase 6 is a FoxO transcription factor-dependent effector in skeletal muscle atrophy.Gamma interferon modulates myogenesis through the major histocompatibility complex class II transactivator, CIITA.Translational signalling, atrogenic and myogenic gene expression during unloading and reloading of skeletal muscle in myostatin-deficient mice.Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.Nuclear effects of G-protein receptor kinase 5 on histone deacetylase 5-regulated gene transcription in heart failure
P2860
Q24601575-D9F02501-E764-492D-ACB0-E12F843E160BQ26778322-27015EBC-D828-4755-AC18-B8584A72BA80Q26783337-FC4AA6CE-ECFA-4863-A0A7-6FFE206C9C4BQ26800197-EB9D82B5-E7F3-4BD9-ACF7-A0AE4AE1E975Q26800207-4BBE46BD-102F-4A2E-A5C6-D99B550C271CQ26999255-B1F0DAE1-132A-40C9-8289-45364F042C9AQ27012762-C34BEF41-5D15-40E6-8C91-D6CB78C51B42Q27316520-4810D13E-DF5C-4B63-AA04-782934849640Q27324722-44A25A3B-A4AA-48B6-8060-6C4652A172B0Q27331653-FF92A172-4253-4EFD-951D-C01BE2496F43Q28542065-57E40AF8-A55A-40AC-B6E3-407F0579E601Q28571869-BA1A8C95-E2EA-41E5-9889-55DD26E9C55EQ28592692-CB15EBBD-7AB6-484C-888A-969000B479A8Q33563647-77A53116-7CEB-4D14-A71C-B1AF537F1D5CQ33722890-4FDCB5FF-E340-47E4-A665-B6350FBD9A6FQ33735893-A4F03588-8749-42C1-8B0B-D7B779C0411EQ33775184-5C828E8F-E6F2-437E-B002-FD3006ECE115Q33802635-EEA2DDD1-CF3F-43CA-A384-2931BFA1D867Q33838571-59544E62-5BE5-4759-9721-31B09C46FB23Q33907984-F091FDF4-86EE-414C-808B-4560690FE114Q33913127-FAC853EC-0DBC-44BE-A8CD-0EE89858F4EBQ33931130-AB74E5CB-5CC5-4AF1-89A1-A43C54A1DAB8Q34016181-4A3FF0D4-B4E7-4E75-8CC2-C927426F5713Q34017528-39D57FA6-BFCE-4A10-B30F-047C56409113Q34200869-FC9D6C14-5315-4382-9B8D-23725ECB08A4Q34256593-31CC3809-21B3-4AAC-A67D-F5A93151C583Q34428648-453A4146-51AC-486A-86C3-A72666D9FE07Q34433210-ECC5FD32-7DD3-4017-BA64-C3AD3ED567DAQ34473863-584FA974-A54E-447A-9944-CD91E6520AD1Q34506085-D5BE614D-88B9-4D6B-94B3-5B6B1B73A53BQ34572209-CFCEA6ED-5506-4293-8128-5F481E4E9690Q34619572-72846A9F-A144-4BC5-B1F2-25CA82AF1535Q34980534-02F16D21-E89F-4FFD-8177-E46F9326A832Q34984485-75E9AE6D-78DD-43BB-A21A-6B069190A96FQ35040190-F58ABEED-AE6A-4B5F-9A76-0DB325898FDFQ35080304-633AED22-0EFF-4596-8A6C-9FECE2493EDCQ35096659-54BD1698-4504-4A86-BB8B-DC7642B495ACQ35144174-4A80E566-505C-485F-8BC5-5BD68AADD0C8Q35219366-FB3A8125-9843-47DB-8E8D-056047F62C9CQ35228115-D6971C2B-87A3-4980-8EC4-3DDB99B53EE8
P2860
Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Myogenin and class II HDACs co ...... inducing E3 ubiquitin ligases.
@en
Myogenin and class II HDACs co ...... inducing E3 ubiquitin ligases.
@nl
type
label
Myogenin and class II HDACs co ...... inducing E3 ubiquitin ligases.
@en
Myogenin and class II HDACs co ...... inducing E3 ubiquitin ligases.
@nl
prefLabel
Myogenin and class II HDACs co ...... inducing E3 ubiquitin ligases.
@en
Myogenin and class II HDACs co ...... inducing E3 ubiquitin ligases.
@nl
P2093
P2860
P1433
P1476
Myogenin and class II HDACs co ...... inducing E3 ubiquitin ligases.
@en
P2093
Andrew H Williams
Eric Meadows
Eric N Olson
James A Richardson
Jesse M Flynn
Johannes Backs
John M Shelton
John McAnally
Matthew J Potthoff
Rhonda Bassel-Duby
P2860
P356
10.1016/J.CELL.2010.09.004
P407
P577
2010-10-01T00:00:00Z